Group 1 - The company held its 23rd meeting of the 7th Board of Directors on September 10, 2025, to discuss various resolutions [2][3][4] - The Board approved the appointment of Li Bo as the new Chief Financial Officer, following the resignation of Zhou Renzhong due to work adjustments [3][16] - The Board also approved a proposal to conduct foreign exchange hedging activities with a limit of up to $60 million, valid for 12 months [4][20][25] Group 2 - The company aims to mitigate foreign exchange market risks and enhance the efficiency of foreign currency usage through the hedging activities [20][22][32] - The hedging activities will include various financial instruments such as forward foreign exchange transactions and foreign exchange options [20][23] - The company has established a strict risk management framework to oversee the hedging activities and ensure compliance with relevant regulations [31][32][33]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss various proposals, including amendments to the Articles of Association and the cancellation of the supervisory board [1][16]. - The meeting will take place on September 12, 2025, at 14:30, in Hefei, Anhui Province, and will utilize both on-site and online voting methods [5][6]. Proposal Summaries Proposal 1: Reappointment of Accounting Firm - The company proposes to reappoint Rongcheng Certified Public Accountants for the 2025 annual audit, citing their independence, objectivity, and experience [6][7]. - The firm has a total revenue of approximately 251 million yuan, with 123 million yuan from securities business, and has served 518 clients [7][8]. Proposal 2: Foreign Exchange Hedging Business - The company plans to engage in foreign exchange hedging to mitigate risks associated with currency fluctuations affecting its export business, which primarily uses USD, EUR, GBP, and JPY [10][11]. - The proposed hedging activities will have a maximum amount of up to 100 million USD or equivalent foreign currency, with a rolling usage within a 12-month period [11][12]. Proposal 3: Cancellation of Supervisory Board - The company intends to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, in compliance with relevant laws and regulations [15][16]. Proposal 4: Amendments to Articles of Association - The company aims to revise its Articles of Association to enhance governance structures in line with the requirements for companies listed on the Sci-Tech Innovation Board [17][18]. - Key amendments include changes to the legal representative's designation and the conditions under which shares can be repurchased [19][20].

Group 1 - The company held its 23rd meeting of the 6th Board of Directors on September 1, 2025, with both in-person and remote participation [1] - The Board decided to cancel 1.725 million shares of unvested restricted stock due to 16 incentive targets leaving the company and one target failing to meet the first vesting period assessment [1][2] - The Board approved the vesting of 2.075 million shares of restricted stock for 36 incentive targets who met the vesting conditions [2] Group 2 - The company plans to increase its foreign exchange hedging business limit to mitigate risks associated with currency fluctuations, with a maximum limit of RMB 500 million or equivalent foreign currency [3] - The peak margin for the foreign exchange hedging business will not exceed RMB 100 million or equivalent foreign currency [3] - The proposal for increasing the foreign exchange hedging limit was approved by the Board and will be submitted for shareholder meeting approval [3][4]

公司将于2025年9月16日召开第三次临时股东大会，审议包括外汇套期保值业务、取消监事会、修订多 项公司治理制度及授权董事会办理工商变更等九项议案。股权登记日为2025年9月10日。 中信证券出具核查意见，认为公司开展外汇套期保值业务的审议程序合法合规，使用自有资金，风险控 制措施完备，不存在损害股东利益的情形。 宏柏新材2025年中报显示，主营收入7.31亿元，同比下降0.16%；归母净利润-2660.55万元，同比下降 345.4%；扣非净利润-3259.63万元，同比下降1251.39%。2025年第二季度单季度主营收入3.75亿元，同 比增长5.7%；单季度归母净利润-2098.63万元，同比下降657.17%；单季度扣非净利润-2447.71万元，同 比下降13670.69%。公司负债率48.49%，毛利率7.86%，财务费用1376.34万元，投资收益122.45万元。 公司公告汇总 宏柏新材第三届董事会第二十一次会议于2025年8月26日召开，审议通过《2025年半年度报告及其摘 要》《2025年半年度募集资金存放与实际使用情况的专项报告》。公司拟以自有资金开展累计不超过 8,000万美元的外汇 ...

Core Viewpoint - The board of directors of Suzhou Xinyi Alloy Tool Co., Ltd. held its 17th meeting of the 5th session, approving several key proposals related to the company's financial reporting, fundraising, profit distribution, governance structure, and operational strategies [1][2][3][4][5][6]. Group 1: Meeting and Voting Results - The meeting was held on August 26, 2025, with all 7 directors present, ensuring compliance with relevant laws and regulations [1]. - All proposals were passed unanimously with 7 votes in favor, and no votes against or abstentions [2][3][4][5][6]. Group 2: Financial Reporting and Fundraising - The 2025 semi-annual report was approved, reflecting the company's financial status and operational results accurately [2]. - A special report on the storage and actual use of raised funds was approved, confirming compliance with regulations and proper usage of funds [2]. - The profit distribution plan for the first half of 2025 was approved, considering the company's profitability and cash flow [3]. Group 3: Governance and Structural Changes - The proposal to abolish the supervisory board and amend the company's articles of association was approved, aligning with new regulatory requirements [3]. - The company plans to increase capital in its wholly-owned subsidiary, Wuhan Xinyi Alloy Tool Co., Ltd., by up to 40 million yuan for project implementation [4]. Group 4: Audit and Risk Management - The company intends to change its accounting firm to Rongcheng Accounting Firm for the 2025 fiscal year [5]. - A proposal to engage in foreign exchange hedging activities with a limit of up to 70 million USD was approved [5]. Group 5: Operational Strategies - The board approved a semi-annual evaluation report on the "Quality Improvement and Efficiency Enhancement" action plan, aimed at enhancing operational efficiency and market competitiveness [6]. - The board agreed to convene the second extraordinary general meeting of 2025, utilizing both in-person and online voting methods [6].

Group 1 - The board of directors of Jiangxi Hongbo New Materials Co., Ltd. held its 21st meeting on August 26, 2025, with all 9 directors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2] - The board approved the half-year report for 2025 and its summary, which will be disclosed on the Shanghai Stock Exchange website [1][2] - The board also approved a special report on the use of raised funds for the first half of 2025, which will also be disclosed on the Shanghai Stock Exchange website [2] Group 2 - The board approved a proposal to conduct foreign exchange hedging business to mitigate risks from currency fluctuations, with a maximum amount of $80 million (or equivalent foreign currency) and a margin limit of 25 million RMB [2][3] - The company has conducted feasibility studies and established internal control systems to ensure that the foreign exchange hedging activities align with operational needs and do not harm the interests of the company and its shareholders [3] Group 3 - The board approved the cancellation of the supervisory board and the corresponding amendments to the company's articles of association, transferring the supervisory functions to the audit committee of the board [4] - The board also approved various amendments to internal regulations, including the rules for shareholder meetings, board meetings, and independent director work systems, all of which require shareholder approval [5][6][7] Group 4 - The board proposed to hold the third extraordinary general meeting of shareholders on September 16, 2025, to review the aforementioned proposals that require shareholder approval [12]

审议结果：表决票 8 票，同意 8 票，反对 0 票，弃权 0 票，表决通过。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《2025 年半年度报告全文》及在《中国证券报》《证券时报》和巨潮资讯网 （公告编号：2025-044）。 证券代码：002855 证券简称：捷荣技术 公告编号：2025-039 东莞捷荣技术股份有限公司 第四届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 东莞捷荣技术股份有限公司（以下简称"公司"）第四届董事会第十九次会议 通知于 2025 年 8 月 21 日发出，会议于 2025 年 8 月 26 日在公司会议室以现场结 合通讯方式召开。会议由董事长张守智先生召集和主持，应参加董事 9 名，实际 参加董事 8 名，其中董事张守智先生、崔真洙先生、郑杰先生、赵小毅先生、独 立董事黄洪燕先生、江金锁先生、韩勇先生以通讯方式出席并表决，董事康凯先 生因个人原因未出席本次会议；全体监事及高级管理人员列席了会议。会议召开 程序符合有关法律、行政法规、部门规章 ...

Core Viewpoint - The company has reported a decline in domestic revenue due to market challenges while achieving growth in overseas markets, driven by strategic innovations and product development [5][6][9]. Group 1: Company Overview - The company focuses on independent innovation and continuous technological advancements to provide high-quality in vitro diagnostic products globally [5]. - The company has not changed its controlling shareholder or actual controller during the reporting period [5]. Group 2: Financial Performance - The company achieved operating revenue of 1.84 billion yuan, a decrease of 1.18% year-on-year, with a total profit of 875 million yuan, down 15.87% year-on-year [9]. - The net profit attributable to shareholders was 771 million yuan, a decrease of 14.62% compared to the previous year [9]. Group 3: Domestic Market Performance - Domestic revenue from in vitro diagnostic services was 1.23 billion yuan, a year-on-year decline of 12.81%, with reagent revenue down 18.96% and instrument revenue up 18.18% [6]. - The company installed 774 units of chemiluminescence immunoassay analyzers, with a 74.81% share of large machines, and served 1,835 tertiary hospitals, achieving a coverage rate of 47.60% [6]. Group 4: International Market Performance - The company established a wholly-owned subsidiary in South Korea and has built operational systems in 14 core countries, enhancing its global brand influence [7]. - Overseas revenue reached 952 million yuan, a year-on-year increase of 19.57%, with reagent business growing by 36.86% [7]. Group 5: Product Development and Sales - The flagship model MAGLUMI X8 has achieved a cumulative installation of 4,300 units, reinforcing the company's leading position in high-end chemiluminescence [8]. - The company has successfully launched the SATLARS T8 automated laboratory line, with a total of 179 lines installed globally [8]. Group 6: Profitability Metrics - The overall gross margin was 68.64%, with instrument gross margin at 26.16%, reflecting a strategic differentiation in product offerings [9].

证券代码：605117 证券简称：德业股份 公告编号：2025-075 宁波德业科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、 董事会会议召开情况 根据《中华人民共和国公司法》 本次会议由张和君先生主持，公司监事、高级管理人员列席了会议。会议的 召开符合《公司法》《公司章程》及其他有关法律、法规的规定，形成决议合法 有效。 二、 董事会会议审议情况 本次会议以书面表决的方式，审议并通过全部议案，形成如下决议： （一）审议通过《2025 年半年度报告及其摘要》 具体内容详见同日披露于上海证券交易所网站（www.sse.com.cn）的《2025 年半年度报告》《2025 年半年度报告摘要》。 表决结果：7 票同意，0 票反对，0 票弃权。 本议案提交董事会审议前，已经公司第三届董事会审计委员会第七次会议全 体审议通过。 （以下简称" 《公司法》"）等有关法律法规及 《宁波德业科技股份有限公司章程》 （以下简称"《公司章程》"）的规定，宁波德 业科技股份有限公司（以下简称"公司"）于 2025 年 8 ...

证券代码：002785 证券简称：万里石 公告编号：2025-041 厦门万里石股份有限公司 第五届董事会第二十三次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、 董事会会议召开情况 厦门万里石股份有限公司（以下简称"公司"）第五届董事会第二十三次会 议于 2025 年 8 月 15 日以邮件和通讯方式发出会议通知，并于 2025 年 8 月 22 日在厦门市思明区湖滨北路 201 号宏业大厦 8 楼公司大会议室以现场结合通讯的 方式召开临时会议。会议应出席董事为 6 人，实际出席董事 5 人（其中董事长胡 精沛先生委托副董事长邹鹏先生表决），本次会议由副董事长邹鹏先生主持，公 司监事、高级管理人员列席了会议，会议的召集和召开符合《中华人民共和国公 司法》和《公司章程》的有关规定，所做决议合法有效。经表决，会议审议通过 议案情况如下： 公司根据实际经营发展需要，拟新增日常关联交易预计，具体如下：新增与 关联公司厦门资生环保科技有限公司（以下简称"资生环保"）签署《业务合作 框架性协议》，预计发生的日常关联交易总额不超过 2,500 万元；新 ...